INHERITED & RARE CV DISEASE: Focus on Cardiomyopathies 14 e 15 Dicembre 2026

Ospedale Vincenzo Monaldi, Piazzale Ettore Ruggeri, Santa Croce, Municipalità 8, Napoli, Campania, 80131, Italia

2026-12-14 - 13:00 (0 disponibili)

2026-12-15 - 09:00 (0 disponibili)

📄 Program-14-15-dec-2026.pdf

The aim of the Academy is to improve the education of cardiologists and other specialist form all the South of Italy regions in the field of rare and genetic Cardiomyopathies and to highlight recent advances, with a particular focus on new approaches to diagnosis and management.

Inherited and rare cardiovascular diseases comprise a group of more than 50 diseases, including primary arrhythmia disorders, malformation syndromes, cardiomyopathies, connective tissue disorders, congenital heart defects and metabolic diseases. Specifically, Cardiomyopathies are diseases that directly affect the cardiac muscle, leading to alterations in both the structure and the pumping function of the heart. They are primarily classified into three main types: Hypertrophic Cardiomyopathy (HCM) is a disease of the cardiac muscle characterized by thickening of the heart walls, particularly the left ventricle, Cardiac Amyloidosis is a disorder that affectsthe cardiac muscle and impairs its function, Fabry Disease is a rare genetic disorder caused by a deficiency of a lysosomal enzyme, leading to the accumulation of lipid substances within the heart.

Early diagnosis of these conditions can be achieved through the recognition of characteristic clinical signs and symptoms, supported by the establishment of a multidisciplinary network at both regional and national levels. Recent advances in scientific research have made available new and significantly more effective therapeutic options. Therefore, there is an urgent need for ongoing scientific updating and the creation of a collaborative network, particularly in the South of Italy, among clinicians involved, in order to ensure timely recognition and appropriate treatment of these diseases with the most suitable therapeutic strategies. In 2025, a pilot Academy program was dedicated to Amyloidosis, involving expert form Campania Region (South of Italy). For 2026, the aim of the Academy is to improve the education of cardiologists and other specialist form all the South of Italy regions in the field of rare and genetic Cardiomyopathies and to highlight recent advances, with a particular focus on new approaches to diagnosis and management.

For 2026, the aim of the Academy is to improve the education of cardiologists and other specialist form all the South of Italy regions in the field of rare and genetic Cardiomyopathies and to highlight recent advances, with a particular focus on new approaches to diagnosis and management.

Scientific Director: Prof. Giuseppe Limongelli

SCIENTIFIC PROGRAM

14th- December 2026

13.00-13.30 Registration

13.30-14.00 - Introduction & Institutional Greetings Rettori: Giovanni Francesco Nicoletti - Lucia Altucci Sen. Elena Murelli – Orfeo Mazzella-Michela Rostan Dr. Ugo Trama Dr.ssa Anna Iervolino Dr. Andrea Bianco Dr. Emilio Di Lorenzo

14.00-14.30 Lecture: The Neglected Disease Jagat Narula (President of the WHF)

14.30-16.30 - Education and research in rare disease: where are we now? Insights from the Networks Chairs: Eduardo Bossone - Giuseppe Limongelli -The European Panorama: Maurizio Scarpa -The ERN Guard Heart: Arthur Wilde - Elena Arbelo -The Council of Genomics - Antoine Bondue -ICON: Perry Elliott -The Swedish-Italian Network: Emanuele Bobbio-Daniela Esposito (SINAPSE) -The Greek Network: Aris Anastasakis -The Rhyad Network: Eduardo Bossone - Zuhair Al-Hassan - Hani Al-Sergani, -Eurordis/Uniamo: Annalisa Scopinaro – Simona Bellagambi

16.30-17.00 Coffee Break

17.00-17.30 Lecture (“A point to consider”): Are we ready for a new CMP Classification? Pro: Eloisa Arbustini Contra: Marco Merlo

17.30-18.15 Inherited and Rare Cardiomyopathies: how scientific societies are increasing the visibility of this field Chairs: Giuseppe Limongelli, Massimo Grimaldi Rete RIAC: Marco Merlo, Cristina Chimenti Rete Fabry: Elena Biagini, Giuseppe Limongelli Rete Cardiomiopatia Ipertrofica: Iacopo Olivotto

ore 18.15-18.30 Le associazioni di pazienti – Valerio PeliniFrancesca Musso

ore 18.30-19.00 Conclusioni

15th December 2026

9.00-9.15 - Introduction & Institutional Greetings

9.15-11.15 - South Regions face to face, good practice and unmet needs in diagnosis and therapy (Amyloidosis, Fabry, Hypertrophic Cardiomyopathy) Chairs: Giuseppe Quintavalle, Ugo Trama, Maurizio Di Mauro, Anna Iervolino Discussant: Gennaro Galasso, Carmine Riccio, Gianluca Di Bella Giuseppina Maura Francese, Maria Maddalena De Francesco, Eugenio Stabile, Ennio Carmine Luigi Pisanò, Marco Vatrano, Alberto Polimeni, Silvio Romano, Antonio Trivisonno. Coordinatori Regionali: Giuseppina Annicchiarico (Puglia), Giulia Motola (Basilicata), Angela Rita Colavita (Molise), Maria Piccione (Sicilia), Giuseppe Limongelli (Campania), Fedele Bevacqua (Calabria)

11.15-11.45 - Coffee Break

11.45 -12.00 The “Rare Battles”. Le squadre di Puglia, Basilicata, Molise, Calabria, Sicilia, Campania si affrontano in una battaglia all’ultimo “quiz” che incoronerà il vincitore della prima edizione “ACADEMY SOUTH RARE BATTLES”. Theme: Diagnosis & Therapy in Amyloidosis, Fabry, Hypertrophic Cardiomyopathy. 1

12.00-12.20 TTR Cardiac Amyloidosis Diagnosis & Therapy – Giuseppe Limongelli

12.20-12.40 Fabry Diagnosis & Therapy – Giuseppe Limongelli

12.40-13.00 Hypertrophic Cardiomyopathy Diagnosis & Therapy - Giuseppe Limongelli

13.00-13.20 Amyloidosis Diagnosis & Therapy: Integrated Patient Management-Giuseppe Limongelli

13.20-13.50: Premiazione, Conclusione e Questionario ECM

The aim of the Academy is to improve the education of cardiologists and other specialist form all the South of Italy regions in the field of rare and genetic Cardiomyopathies and to highlight recent advances, with a particular focus on new approaches to diagnosis and management.

Il programma completo, comprensivo di sessioni, orari, temi trattati e relatori, è disponibile nella sezione “Programma” della pagina evento. Per approfondire i contenuti o conoscere i CV dei relatori, possiamo inviarti materiale dettagliato su richiesta.

Può scaricare il programma cliccando il seguente link: Razionale e Programma Scientifico

L'evento si terrà il 14 e 15 Dicembre 2026, presso Monaldi Hospital - Aula Centro Ricerca Napoli

Sì, per motivi organizzativi e logistici i posti sono limitati ad un massimo di 0 partecipanti.
Ti consigliamo di iscriverti al più presto per garantirti la partecipazione.

Le condizioni di cancellazione, eventuali rimborsi o la possibilità di sostituire un partecipante sono indicate nei termini e condizioni dell’iscrizione.
In caso di limitazioni o emergenze sanitarie, valuteremo soluzioni alternative (come la partecipazione in modalità online).

Per qualsiasi chiarimento o esigenza, puoi scrivere a info@limenagency.it o chiamare il 089 2884627.
Siamo disponibili anche per richieste specifiche legate all’accessibilità, alla logistica o alla partecipazione in gruppo.

INHERITED & RARE CV DISEASE: Focus on Cardiomyopathies 14 e 15 Dicembre 2026

The aim of the Academy is to improve the education of cardiologists and other specialist form all the South of Italy regions in the field of rare and genetic Cardiomyopathies and to highlight recent advances, with a particular focus on new approaches to diagnosis and management.

For 2026, the aim of the Academy is to improve the education of cardiologists and other specialist form all the South of Italy regions in the field of rare and genetic Cardiomyopathies and to highlight recent advances, with a particular focus on new approaches to diagnosis and management.

SCIENTIFIC PROGRAM

The aim of the Academy is to improve the education of cardiologists and other specialist form all the South of Italy regions in the field of rare and genetic Cardiomyopathies and to highlight recent advances, with a particular focus on new approaches to diagnosis and management.

Prenota: INHERITED & RARE CV DISEASE: Focus on Cardiomyopathies 14 e 15 Dicembre 2026